Novo Nordisk ups steerage after Q1 outcomes beat expectations 2021-05-05T16:16:12-04:00May 5th, 2021| share this article!Denmark’s Novo Nordisk (NOVOb.CO), the world’s greatest producer of diabetes medication, raised its monetary forecast in native currencies on Wednesday after reporting first quarter gross sales and earnings above expectations. Learn Extra share this article! Related Posts Amgen Jumps on Obesity Drug Hope. What’s Next. May 3rd, 2024 At Berkshire’s Meeting, Emotion Will Top Business May 3rd, 2024 Ice Cold on Coca-Cola? May 3rd, 2024 Trump Media Auditing Firm Charged With Fraud May 3rd, 2024
